Sean M Kelley

US Patent:

7149523, Dec 12, 2006

Filed:

Nov 4, 2003

Appl. No.:

10/701095

Inventors:

Christopher R. Schmidt - Pinole CA, US
John M. Harris - Chicago IL, US
Sean S. Kelley - Hoffman Estates IL, US

Assignee:

Motorola, Inc. - Schaumburg IL

International Classification:

H04Q 7/00

US Classification:

455436, 455440, 455 6711, 455423, 370331

Abstract:

Apparatus and method for performing radio environment reporting on a reverse common signaling channel. When a dedicated RF connection between a remote unit (RU) () and infrastructure equipment () is being released, the RU receives a first message from the infrastructure instructing the RU to perform occasional pilot strength reporting on the reverse common signaling channel (r-csch) while the RU is in the idle state. In the preferred embodiment, the pilot strength reporting is limited by a maximum number of reports and/or a time limit to preserve battery life and prevent r-csch congestion in the system. Preferably, a Radio Environment Report Message, referred to generally herein as a second message, carries radio environment information (REI), such as pilot strength and phase of the best pilots measured, and helps the infrastructure both with tracking the RU location and with selecting a strong set of pilots for channel assignment.

US Patent:

20040005314, Jan 8, 2004

Filed:

Jan 23, 2003

Appl. No.:

10/333712

Inventors:

Enrique Escandon - Belmont CA, US
Sean Kelley - San Mateo CA, US
Hong Xiang - Palo Alto CA, US
Judith Fox - , US

International Classification:

A61K039/395
A61N005/00

US Classification:

424/141100, 424/144100, 600/001000

Abstract:

Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.

US Patent:

20090169569, Jul 2, 2009

Filed:

Sep 12, 2008

Appl. No.:

12/283526

Inventors:

Enrique Escandon - Belmont CA, US
Sean K. Kelley - San Mateo CA, US
Hong Xiang - Palo Alto CA, US
Judith A. Fox - San Francisco CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

A61K 39/395
C12N 5/06
A61K 38/17

US Classification:

4241721, 435375, 514 12

Abstract:

Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.

US Patent:

20110059104, Mar 10, 2011

Filed:

Jul 29, 2010

Appl. No.:

12/804789

Inventors:

Enrique Escandon - Redwood City CA, US
Sean K. Kelley - San Mateo CA, US
Hong Xiang - Palo Alto CA, US
Judith A. Fox - San Francisco CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

A61K 39/395
A61P 35/00
C12N 5/02
A61K 38/00

US Classification:

4241581, 435375, 514 193

Abstract:

Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.

US Patent:

20200399376, Dec 24, 2020

Filed:

Feb 26, 2019

Appl. No.:

16/975549

Inventors:

- South San Francisco CA, US
Sean Keith KELLEY - Burlingame CA, US
Namrata Srivastava PATIL - Sunnyvale CA, US

International Classification:

C07K 16/28
G01N 33/50
C12N 15/10
C12Q 1/6825

Abstract:

The invention provides methods of dosing for the treatment of cancers. In particular, provided are methods for treating human patients having lung cancer, such as non-small cell lung cancer (NSCLC), by administering a combination of an anti-TIGIT antagonist antibody and an anti-PD-L1 antagonist antibody.

US Patent:

20180096746, Apr 5, 2018

Filed:

Sep 30, 2016

Appl. No.:

15/282916

Inventors:

- Palo Alto CA, US
Rachel Rieger - Redwood City CA, US
Dusan Baic - Santa Clara CA, US
Sean Kelley - Menlo Park CA, US

International Classification:

G21K 1/10

Abstract:

In a beam filter assembly, a base filter is employed to modify a beam quality of a radiation beam of a base energy level and a first filter slice is stacked with the base filter to modify a beam quality of a radiation beam of a first energy level higher than the base energy level. In a beam filter positioning device, a base stage carries a base filter and a first stage carries a filter slice. The base stage is provided with a first engagement site and a second engagement site. The first stage is provided with a first engagement site, a second engagement site, and an open port. The first stage and the base stage are each independently movable relative to the beamline. The first stage is engageable with the base stage when at least one of the first and second engagement sites of the first stage is aligned with at least one of the first and second engagement sites of the base stage, and is further movable with the base stage in unison when engaged.